Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
AMRX

Amneal Pharmaceuticals, Inc. (AMRX)

NASDAQ
$21.89
+$0.77
(+3.67%)
Previous Close: ⁦$21.12⁩
Market Closed

Last updated: ⁦2026-11-19 04:08:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Amneal Pharmaceuticals, Inc. (AMRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $21.89, with a market capitalization of $7.40B and a P/E ratio of 55.20. Over the past 52 weeks, its price has ranged from $11.39 to $22.12. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$7.40B

$21.07

$22.12

$20.94

$21.12

1.53M

3.17M

55.20

$22.12

$11.39

--

2026-09-30

Amneal Pharmaceuticals, Inc. (AMRX) Latest Closing Stock Price

Amneal Pharmaceuticals, Inc. (AMRX) last closed at $21.89 as of 2026-11-19 00:58:00, up 3.67% ($0.77) from the previous close of $21.12.

During the latest regular trading session, AMRX traded between $20.94 and $22.12, with a volume of 1.53M shares. The closing price was near the upper end and near the upper end of its 52-week range.

Amneal Pharmaceuticals, Inc. (AMRX) 7-Day Stock Price Change

Over the past seven days, Amneal Pharmaceuticals, Inc. (AMRX) moved from $21.28 to $21.89, representing a gain of 2.86% ($0.61).

The stock traded between $20.29 and $22.12 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 2.11 million shares, down versus the previous seven-day period, indicating lower trading activity.

AMRX 52-Week Price Position

Position in Range: 97.8%

52W Low$11.39
52W High$22.12

AMRX is currently trading at $21.89, placing it 97.8% of the way from its 52-week low of $11.39 to its 52-week high of $22.12. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Amneal Pharmaceuticals, Inc. (AMRX)?

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Amneal Pharmaceuticals, Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
8,500
Exchange
NASDAQ
Company Website

AMRX News

Latest news related to Amneal Pharmaceuticals, Inc. and AMRX stock.

  • Benzinga

    Amneal Announces European Approval of Adcomfo

    Read Full Article
  • Benzinga

    'UK Drugmaker in Talks to Boost Estrogen Patch Supply in US' - Bloomberg

    https://www.bloomberg.com/news/articles/2026-11-16/uk-drugmaker-in-talks-to-boost-estrogen-patch-supply-in-us

    Read Full Article
  • Massive

    Here's Why You Should Add AURA Stock to Your Portfolio Now

    Aura Biosciences completed enrollment and dosing in its phase III CoMpass study evaluating bel-sar for early choroidal melanoma treatment. Top-line data is expected in the second half of 2027. If successful, bel-sar could become the first FDA-approved frontline vision-preserving therapy for this indication. The company is also exploring bel-sar for choroidal metastases and ocular surface cancers, with updates expected in Q1 2027. AURA shares have risen 39.6% year-to-date.

    Read Full Article
  • Massive

    Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief

    Zoetis announced USDA approval for Cytopoint Plus, a monoclonal antibody therapy providing 75 days of relief from allergic itch in dogs. The extended dosing interval is approximately 1.5 times longer than existing mAb options, expanding Zoetis' canine dermatology portfolio alongside Cytopoint, Apoquel, and Apoquel Chewable. Market uptake will depend on pricing, veterinary recommendations, and real-world performance.

    Read Full Article
  • Massive

    BEAM Stock Falls 7% Despite Meeting Primary Endpoints in SCD Study

    Beam Therapeutics reported positive top-line results from its BEACON study for risto-cel, a gene-editing therapy for sickle cell disease, achieving primary efficacy and safety endpoints with patients demonstrating freedom from severe vaso-occlusive crises for at least 12 consecutive months. The company plans to submit a biologics license application to the FDA by end of 2026, potentially marking the first commercial product approval for a base-editing therapy. Despite the encouraging clinical results, BEAM shares declined 7% following the announcement, likely due to concerns over weaker third-quarter results and profit-taking.

    Read Full Article

Ways to Trade AMRX at MEXC

AMRX MEXC RealStocks

Own real AMRX shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

How to Buy Amneal Pharmaceuticals, Inc. (AMRX) Stock on MEXC

Eligible investors can buy real shares of Amneal Pharmaceuticals, Inc. (AMRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for AMRX and Place Your Order
Step 3: Search for AMRX and Place Your Order
Open the RealStocks trading page and search for AMRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Amneal Pharmaceuticals, Inc. (AMRX) stock price today?
Amneal Pharmaceuticals, Inc. (AMRX) is currently trading at $21.89, up 3.67% ($0.77) from the previous close of $21.12. Intraday prices update in real time during regular trading hours.
2.Is AMRX stock going up or down today?
As of 2026-11-19 00:58:00, AMRX is trading at $21.89, up 3.67% ($0.77) from its previous close of $21.12. The stock has traded between $20.94 and $22.12 during today’s regular session. Past price movements do not guarantee future results.
3.What is AMRX pre-market price?
As of 2026-11-19 00:58:00, AMRX is trading at $21.24 in pre-market trading, up 0.57% ($0.12) from the previous close of $21.12. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is AMRX after-hours price?
As of 2026-11-19 00:58:00, AMRX is trading at $21.63 in after-hours trading, down 1.19% ($0.26) from the regular-session close of $21.89. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is AMRX stock trading now?
AMRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does AMRX sit relative to its 52-week high and low?
Over the past 52 weeks, AMRX has traded between a low of $11.39 and a high of $22.12. At $21.89, the stock is positioned 97.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Amneal Pharmaceuticals, Inc. in?
Amneal Pharmaceuticals, Inc. (AMRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Amneal Pharmaceuticals, Inc.'s market capitalization and where is it listed?
Amneal Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $7.40B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is AMRX valued in terms of P/E ratio and EPS?
AMRX trades at a P/E ratio of 55.20, based on trailing-twelve-month EPS of $0.38. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Amneal Pharmaceuticals, Inc. pay a dividend?
Amneal Pharmaceuticals, Inc. pays an indicated annual cash dividend of $0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to AMRX, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

AMRX Stock Calculator

Estimate the value between AMRX shares and USD.

AMRX Shares to USD

AMRX Shares
AMRX
AMRX
USD
USD
USD

1.00 AMRX shares = 21.889 USD

Calculations are estimates based on the latest available price and are for reference only.